HIV-1 DNA predicts disease progression and post-treatment virological control
In HIV-1 infection, a population of latently infected cells facilitates viral persistence despite antiretroviral therapy (ART). With the aim of identifying individuals in whom ART might induce a period of viraemic control on stopping therapy, we hypothesised that quantification of the pool of latent...
Main Authors: | James P Williams, Jacob Hurst, Wolfgang Stöhr, Nicola Robinson, Helen Brown, Martin Fisher, Sabine Kinloch, David Cooper, Mauro Schechter, Giuseppe Tambussi, Sarah Fidler, Mary Carrington, Abdel Babiker, Jonathan Weber, Kersten K Koelsch, Anthony D Kelleher, Rodney E Phillips, John Frater, on behalf of the SPARTAC trial investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2014-09-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/03821 |
Similar Items
-
HIV-1 DNA predicts disease progression and post-treatment virological control.
by: Williams, J, et al.
Published: (2014) -
Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
by: Gossez, M, et al.
Published: (2018) -
Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
by: Evelyn Y. Bonney, et al.
Published: (2021-03-01) -
Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal
by: Van Rompay Koen K A, et al.
Published: (2012-07-01) -
Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
by: Adele S. Benzaken, et al.
Published: (2019-08-01)